Retatrutide Weight Loss | Regal Weight Loss — DFW's Premier Clinic
Regal Weight Loss Free Consultation ↓
Now Available — Dallas–Fort Worth

The Weight Loss Medication
That Outperforms Everything Else

Retatrutide's triple-receptor mechanism produced 24.2% average body weight loss in clinical trials — more than semaglutide and tirzepatide combined could claim. Physician-supervised therapy, personalized to you.

24.2% Avg. weight loss
(Phase 2 trials, 48 wks)
Hormone receptors
targeted simultaneously
48 wk Results in less time
than comparable trials
Schedule My Free Consultation — Fill Out the Form Below No commitment required  ·  DFW physicians  ·  Same-week appointments available
Licensed Medical Physicians
Serving All DFW — Dallas, Plano, Mesquite, Arlington, Fort Worth & Grand Prairie
Same-Week Consultations
Ongoing Physician Monitoring

Three Receptors. One Injection. Unprecedented Results.

Every other weight loss medication — including Ozempic, Wegovy, Mounjaro, and Zepbound — targets one or two hormone receptors. Retatrutide targets three simultaneously, engaging biology that no other drug can reach.

Receptor 1 — Also in Ozempic & Mounjaro

GLP-1
Appetite & Blood Sugar

Signals the brain to reduce hunger, slows gastric emptying, and regulates insulin after meals. The foundation of all modern weight loss medications.

Appetite Control
Receptor 2 — Also in Mounjaro/Zepbound

GIP
Metabolic Efficiency

Amplifies the insulin response after eating and enhances how efficiently your cells use glucose — the upgrade that made tirzepatide outperform semaglutide.

Enhanced Metabolism
Receptor 3 — Exclusive to Retatrutide

Glucagon
Fat Burn & Metabolic Rate

Instructs the liver to release stored energy and raises your resting metabolic rate — so your body burns more calories around the clock, even at rest.

The Differentiator
+4–5%
The glucagon advantage over tirzepatide. Clinical data suggests retatrutide's third receptor is directly responsible for an additional 4–5% average body weight loss beyond what tirzepatide can achieve — representing a meaningful clinical difference, not a marginal one.

Retatrutide vs. Semaglutide vs. Tirzepatide

If you've tried Ozempic, Wegovy, Mounjaro, or Zepbound — or if you're evaluating options for the first time — here's how the clinical evidence stacks up.

Semaglutide
(Ozempic / Wegovy)
Tirzepatide
(Mounjaro / Zepbound)
Retatrutide
Available at Regal
Receptors Targeted GLP-1 only GLP-1 + GIP GLP-1 + GIP + Glucagon Best
Avg. Weight Loss ~15% body weight ~20% body weight ~24.2% body weight Best
Trial Duration 68 weeks (STEP 1) 72 weeks (SURMOUNT-1) 48 weeks — better results, faster
Resting Metabolic Rate ✗ No effect ✗ No effect ✓ Increased via glucagon
Fat Breakdown (Lipolysis) ✗ Indirect only ✗ Indirect only ✓ Direct activation
Administration Weekly injection Weekly injection Weekly injection
Available at Regal WL ✓ Yes ✓ Yes ✓ Yes (via compounding)

Clinical trial results are from independent studies (STEP 1, SURMOUNT-1, Phase 2 TRIUMPH). Cross-trial comparisons should be interpreted with appropriate caution due to differences in study design and populations. All medications available subject to physician evaluation.

What the Phase 2 Data Actually Shows

The NEJM-published Phase 2 TRIUMPH trial enrolled 338 adults over 48 weeks — double-blind, placebo-controlled. The results were unlike anything previously recorded in weight loss pharmacotherapy.

24.2%
Average body weight reduction at 12mg dose over 48 weeks — unmatched in any randomized controlled trial for an anti-obesity medication
18.9 cm
Average waist circumference reduction at highest dose — a clinically meaningful reduction in visceral fat
17.5%
Average weight loss even at the 4mg dose — strong evidence-based results even without the maximum dose
Not ↓
The weight loss curve had not plateaued by week 48 — suggesting continued results with longer treatment duration

Average Weight Loss — How the Medications Compare

Semaglutide
~15% / 68 wks
Tirzepatide
~20% / 72 wks
Retatrutide
~24.2% / 48 wks

Phase 2 results are from a double-blind, placebo-controlled study (Jastreboff et al., NEJM 2023). Retatrutide is not yet FDA-approved; it is available through licensed compounding pharmacies under physician supervision. Individual results will vary. Regal Weight Loss physicians evaluate all patients before recommending any medication.

Who Is Retatrutide Right For?

Retatrutide is not right for everyone — and matching the right therapy to the right patient is exactly what a Regal Weight Loss physician consultation is designed to determine. That said, here's a general picture of who tends to be the best fit.

✓ Strong Candidates

  • BMI ≥ 30, or BMI ≥ 27 with a weight-related condition (high blood pressure, type 2 diabetes, sleep apnea, high cholesterol)
  • Patients who plateaued on semaglutide (Ozempic / Wegovy) and want more
  • Patients who responded to tirzepatide but want to push further
  • Those with insulin resistance, elevated triglycerides, or metabolic syndrome — glucagon activation is particularly beneficial here
  • Higher starting BMI (40+) requiring a medication with evidence for substantial, sustained loss
  • Motivated, committed patients ready for a physician-supervised program

→ Important Considerations

  • Not appropriate for patients with personal or family history of medullary thyroid carcinoma (MTC)
  • Not appropriate for Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Not for use during pregnancy or in patients planning to conceive in the near term
  • History of pancreatitis requires physician evaluation before starting any GLP-1 class medication
  • Our physicians will review your complete medical history before any recommendation is made — eligibility is determined case by case

Physician-Supervised. Personalized. Proven.

Retatrutide is a powerful tool — but its results depend entirely on how it's managed. At Regal Weight Loss, every patient receives a program built around their specific health profile, not a one-size-fits-all protocol.

Comprehensive Medical Evaluation

Full health history review, baseline labs, and metabolic assessment before any prescription is written. We treat you as an individual, not a number on a scale.

Licensed DFW Physicians

Our physicians stay at the leading edge of obesity medicine — including retatrutide — so our patients always have access to the most advanced, evidence-based options available.

Ongoing Monitoring & Dose Management

Supervised escalation, regular follow-ups, lab tracking, and responsive dose adjustments — the difference between results and disappointment is how well-managed your therapy is.

Personalized Protocol — Not a Template

Your starting dose, escalation timeline, and maintenance plan are built around your body — not a generic protocol. Individualized dosing is what separates outcomes at Regal from cookie-cutter programs.

All Three Options Under One Roof

Semaglutide, tirzepatide, and retatrutide — all available. Our physicians will recommend what's right for you, not simply what's newest or most popular.

Long-Term Maintenance Planning

We don't stop at goal weight. Every Regal patient receives a thoughtful long-term maintenance strategy to protect and sustain the results they've worked to achieve.

Frequently Asked Questions

Our physicians answer these questions every day. Here are the most common ones — but your best answers will come in a one-on-one consultation.

Retatrutide is currently in Phase 3 clinical trials and is not yet FDA-approved as a standalone medication. However, it may be available through licensed medical providers via compounding pharmacies while Phase 3 trials are ongoing. At Regal Weight Loss, our physicians prescribe retatrutide through licensed compounding channels, under the same physician-supervised framework we apply to all treatments. Our physicians will review the current regulatory status with you during your consultation.
The key difference is the glucagon receptor. Tirzepatide (Mounjaro, Zepbound) targets GLP-1 and GIP receptors, which reduce appetite and improve insulin response. Retatrutide adds glucagon receptor activation, which increases resting metabolic rate and directly promotes the breakdown of stored fat — something tirzepatide simply cannot do. The clinical data reflects this: retatrutide produced approximately 24.2% average weight loss vs. tirzepatide's ~20%, in a shorter trial period.
Yes — and patients who have plateaued on semaglutide or tirzepatide are actually among the strongest candidates for retatrutide. The triple-receptor mechanism engages pathways that prior medications didn't address, which is why many patients who felt "stuck" on other medications see renewed progress on retatrutide. Your Regal physician will review your medication history and determine the right transition or combination approach.
Retatrutide is administered as a once-weekly subcutaneous injection — a small injection just under the skin in the abdomen, thigh, or upper arm. Most patients report minimal discomfort. Our care team provides complete injection training at your first treatment appointment so you feel fully confident administering it at home.
The most common side effects are gastrointestinal — nausea, mild vomiting, diarrhea, or constipation — and they're most pronounced during the dose escalation phase. Our structured escalation protocol is specifically designed to minimize these effects, and most patients find them manageable and temporary. Serious side effects are uncommon. Your Regal physician will review all potential side effects and monitoring protocols with you before you begin, and you'll have access to our care team between appointments if anything arises.
Your free consultation is a one-on-one conversation with a Regal Weight Loss clinician. We review your health history, weight loss goals, prior medication experience, and any relevant health conditions. At the end, you'll receive a clear, personalized recommendation — whether that's retatrutide, tirzepatide, semaglutide, or a different approach entirely — along with a plan tailored specifically to you. There's no obligation and no pressure.

Ready to Explore What
Retatrutide Can Do for You?

Schedule a free consultation with a Regal Weight Loss physician. We'll review your health history, answer every question you have, and build a program perfectly suited to you — whether that's retatrutide or another evidence-based approach.

Serving Dallas · Fort Worth · Arlington · Plano · Mesquite · Grand Prairie

© 2025 Regal Weight Loss  ·  Privacy Policy  ·  Terms of Use

Retatrutide is not FDA-approved. Available through licensed compounding pharmacies under physician supervision. Results vary. This page is not intended as medical advice. All treatment decisions are made by licensed physicians following a comprehensive medical evaluation. Regal Weight Loss serves patients in Dallas, Fort Worth, Arlington, Plano, Mesquite, and Grand Prairie, Texas.